Lung Stent Market Size, Share, Opportunities, And Trends By Type (Tracheobronchial Stents, Laryngeal Stents), By Product Type (Self-Expandable, Balloon-Expandable, Non-Expandable), By Product Material (Metal (Nitinol, Stainless Steel, Others), Silicone, Hybrid), By End-User (Hospitals, Ambulatory Surgery Center, Others), And By Geography - Forecasts From 2025 To 2030

  • Published : Mar 2025
  • Report Code : KSI061613777
  • Pages : 145
excel pdf power-point

Lung Stent Market Size:

The lung stent market is estimated at US$156.320 million in 2025 and is expected to grow at a CAGR of 5.3% to attain US$202.422 million in 2030.

A lung stent is a type of hollow tube placed through the patient's airway. The lung stent helps in opening the narrowed area in the respiratory system. It is primarily used to treat airway and lung diseases, as well as chronic conditions such as asthma, central airway obstruction, chronic obstructive pulmonary disease, glaucoma, and lung cancer, among others. Irregular granulation tissue, lung cancer, metastatic malignancies, infections, TB, lymphoma, or other inflammatory illnesses can also cause narrowed or stenotic air passages. In most cases, tracheobronchial (airway) stents are devices that are used to splint narrowed airways open. The innovations of the stent technology are also among the factors propelling the lung stent market’s growth during the estimated timeline. Similarly, the changing regulatory environment for medical technology is also estimated to boost the demand for lung stents.


Lung Stent Market Overview & Scope:

The lung stent market is segmented by:

  • Type: By type, the global lung stent market is categorized into tracheobronchial stents and laryngeal stents. The tracheobronchial stents category is estimated to grow significantly as they offer more efficient therapy.
  • Product Type: By product type, the market is divided into self-expandable, balloon-expandable, and non-expandable. The self-expandable category is expected to grow at a greater rate.
  • Product Material: By product material, the market is divided into metal, silicone, and hybrid. The metal category is estimated to grow considerably and is further categorized into nitinol, stainless steel, and others.
  • End-User: By end-user, the global lung stent market is divided into hospitals, ambulatory surgery centers, and others. The hospital segment is estimated to attain a greater growth rate.
  • Region: The Asia Pacific region is estimated to grow at a significant rate during the forecasted timeline, in the global lung stent market. The major factor propelling the region's growth is the increasing development in the healthcare and medical technology sector. The region witnessed major growth in its medical technology sector, especially in countries like India, Malaysia, and Japan. Similarly, the rising population of older individuals in the region is also estimated to boost the demand.

Top Trends Shaping the Lung Stent Market:

1. Introduction of 3D printing technology

  • The introduction of key innovations in stent technologies, including 3D printing technology, helps in creating customized lung stents, which helps in offering more efficient solutions and patient satisfaction.

2. Shift in surgical practices

  • The changing global surgical practices, which include increasing demand for minimally invasive surgical practices, are also among the key factors propelling the market's growth.

Lung Stent Market Growth Drivers vs. Challenges:

Opportunities:

  • Growing prevalence of lung cancer: The increasing global cases of lung cancer are among the key factors propelling the lung stent market growth during the forecasted timeline. In lung cancer patients, these stents help open the blocked airways. The global lung cancer cases witnessed a major growth during the past few years. The Canadian Cancer Society, in its report, stated that the total projected cases of lung cancer in Canada is projected to reach 17,300, increasing from 15,800 cases in 2023.
  • Growing older population: The increasing global population of older individuals is among the key factors propelling the lung stent market growth. With the increasing older population, the lung stent helps in maintaining airway patency and alleviating respiratory distress.

Challenges:

  • Limited awareness: The lack of consumer awareness of the individual for airway stent treatment is among the key factors challenging market growth.

Lung Stent Market Regional Analysis:

  • North America: The North American region is forecasted to attain a greater market share in the global lung stent market due to its rapid advancement in medical technologies. The region is among the most developed and fastest adopters of new-age technologies, like 3D printing technology, in the healthcare sector. Furthermore, the introduction of key governmental initiatives and policies to boost the development of healthcare infrastructure is also estimated to boost the regional market expansion.

Lung Stent Market Competitive Landscape:

The market is fragmented, with many notable players including Boston Scientific Corporation, Novatech SA, Boston Medical Products, Inc., Fuji Systems Corporation, Cook Group, Hood, E.Benson Laboraories, Inc., Merit Medical Systems, Taewoong (Olympus Global), Micro-Tech (Nanjing) Co., Ltd., S&G Biotech, Stening, MicroPort Scientific Corporation, Thoracent, Inc., and AMETEK Inc. among others.


Lung Stent Market Scope:

Report Metric Details
Lung Stent Market Size in 2025 US$156.320 million
Lung Stent Market Size in 2030 US$202.422 million
Growth Rate CAGR of 5.3%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Forecast Unit (Value) USD Million
Segmentation
  • Type
  • Product Type
  • Product Material
  • End-User
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Lung Stent Market
  • Boston Scientific Corporation
  • Novatech SA
  • Boston Medical Products, Inc.
  • Fuji Systems Corporation
  • Cook Group
Customization Scope Free report customization with purchase

 

The Lung Stent Market is analyzed into the following segments:

By Type

  • Tracheobronchial Stents
  • Laryngeal Stents

By Product Type

  • Self-expandable
  • Balloon-expandable
  • Non-expandable

By Product Material

  • Metal
    • Nitinol
    • Stainless Steel
    • Others
  • Silicone
  • Hybrid

By End-User

  • Hospitals
  • Ambulatory Surgery Center
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Frequently Asked Questions (FAQs)

The lung stent market is expected to reach a total market size of US$202.422 million by 2030.

Lung Stent Market is valued at US$156.320 million in 2025.

The lung stent market is expected to grow at a CAGR of 5.3% during the forecast period.

The major factor that will continue to augment the growth of the lung stent market during the forecast period is the increasing demand for minimally invasive surgery to treat chronic conditions affecting the lungs.

The North American region is anticipated to hold a significant share of the lung stent market.

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. LUNG STENT MARKET BY TYPE

5.1. Introduction

5.2. Tracheobronchial Stents

5.3. Laryngeal Stents

6. LUNG STENT MARKET BY PRODUCT TYPE

6.1. Introduction

6.2. Self-expandable

6.3. Balloon-expandable

6.4. Non-expandable

7. LUNG STENT MARKET BY PRODUCT MATERIAL

7.1. Introduction

7.2. Metal

7.2.1. Nitinol

7.2.2. Stainless Steel

7.2.3. Others

7.3. Silicone

7.4. Hybrid

8. LUNG STENT MARKET BY END-USER

8.1. Introduction

8.2. Hospitals

8.3. Ambulatory Surgery Center

8.4. Others

9. LUNG STENT MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. By Type

9.2.2. By Product Type

9.2.3. By Product Material

9.2.4. By End-User

9.2.5. By Country

9.2.5.1. USA

9.2.5.2. Canada

9.2.5.3. Mexico

9.3. South America

9.3.1. By Type

9.3.2. By Product Type

9.3.3. By Product Material

9.3.4. By End-User

9.3.5. By Country

9.3.5.1. Brazil

9.3.5.2. Argentina

9.3.5.3. Others

9.4. Europe

9.4.1. By Type

9.4.2. By Product Type

9.4.3. By Product Material

9.4.4. By End-User

9.4.5. By Country

9.4.5.1. United Kingdom

9.4.5.2. Germany

9.4.5.3. France

9.4.5.4. Spain

9.4.5.5. Others

9.5. Middle East and Africa

9.5.1. By Type

9.5.2. By Product Type

9.5.3. By Product Material

9.5.4. By End-User

9.5.5. By Country

9.5.5.1. Saudi Arabia

9.5.5.2. UAE

9.5.5.3. Others

9.6. Asia Pacific

9.6.1. By Type

9.6.2. By Product Type

9.6.3. By Product Material

9.6.4. By End-User

9.6.5. By Country

9.6.5.1. China

9.6.5.2. Japan

9.6.5.3. India

9.6.5.4. South Korea

9.6.5.5. Taiwan

9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Boston Scientific Corporation

11.2. Novatech SA

11.3. Boston Medical Products, Inc.

11.4. Fuji Systems Corporation

11.5. Cook Group

11.6. Hood, E.Benson Laboraories, Inc.

11.7. Merit Medical Systems

11.8. Taewoong (Olympus Global)

11.9. Micro-Tech (Nanjing) Co., Ltd.

11.10. S&G Biotech

11.11. Stening

11.12. MicroPort Scientific Corporation

11.13. Thoracent, Inc.

11.14. AMETEK Inc.

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

Boston Scientific Corporation

Novatech SA

Boston Medical Products, Inc.

Fuji Systems Corporation

Cook Group

Hood, E.Benson Laboraories, Inc.

Merit Medical Systems

Taewoong (Olympus Global)

Micro-Tech (Nanjing) Co., Ltd.

S&G Biotech

Stening

MicroPort Scientific Corporation

Thoracent, Inc.

AMETEK Inc.